DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

Be at least 18 years of age on the day of signing the informed consent.

Be HIV-1 positive as determined according to national testing strategies

Have a plasma HIV-1 RNA ≥1000 copies/mL within 30 days prior to the randomization,

Have HIV treatment indication based on physician assessment according to local treatment guidelines